BOTHELL, Wash., Sept. 28 /PRNewswire/ -- Verathon Inc. is pleased to announce that it has once again been ranked in the prestigious Technology Fast 50 Program for Washington State, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area by Deloitte & Touche LLP, one of the nation's leading professional services organizations. Verathon(R), which is privately held, ranked 27th on the list with growth of 142.5%. Rankings are based on percentage revenue growth over a five-year period from 2002-2006. This is the fourth time in the past six years that Verathon(R) (formerly Diagnostic Ultrasound) has been ranked in Deloitte's Fast 50.
"It has been a terrific year for us with strong growth coming from both our new GlideScope(R) video laryngoscope brand, as well as our flagship BladderScan(R) brand," said Gerald McMorrow, CEO of Verathon Inc. "Our accelerated growth is directly tied to our exceptional team of employees worldwide, our supportive shareholders, and in particular to our loyal customers; dedicated health care professionals who are working hard to improve patient care."
"To rank on Deloitte's Technology Fast 50, companies must have phenomenal revenue growth over five years, said Larry Hile, the Managing Partner in Deloitte's Technology, Media and Telecommunications (TMT) industry practice based in Seattle. Verathon(R) has proven to be one of the fast-growth success stories in Washington State and we applaud their dedication to making their vision a reality."
Verathon(R) designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company is best know for its BladderScan(R) brand, a line of noninvasive bladder volume measurement instruments used in Urology, Acute Care, Primary Care, and Extended Care. BladderScan(R) helps diagnose urinary-related problems such as enlarged prostate (BPH) and overactive bladder (OAB), and is clinically proven to prevent unnecessary urinary catheterizations and reduce rates of urinary tract infection. The company also manufactures and markets the innovative GlideScope(R) video laryngoscope (GVL(R)). GlideScope(R) provides a consistently clear view of the airway, enabling quick intubation, and offers significant benefits to Anesthesiology, Emergency, Critical Care, EMS professionals. GlideScope(R) is also being used by the military in both Afghanistan and Iraq.
To qualify for the Technology Fast 50, companies must have had operating revenues of at least $50,000 in 2002 and $5,000,000 in 2006, be headquartered in North America, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify.
Winners of the 16 regional Technology Fast 50 programs in the United States and Canada are automatically entered in Deloitte's Technology Fast 500 program, which ranks North America's top 500 fastest growing technology, media, telecommunications and life sciences companies. For more information on Deloitte's Technology Fast 50 or Technology Fast 500 programs, visit http://www.fast500.com.
About Verathon Inc.
Verathon(R), formerly Diagnostic Ultrasound Corp., designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan(R) instrument is the standard of care for bladder volume measurement. The brand is found in over 60 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon(R) entered Anesthesiology, Critical Care and Emergency markets with the GlideScope(R) video laryngoscope (GVL(R)) brand. Verathon(R) is headquartered in Bothell, Washington and has approximately 280 employees worldwide. For more information, please visit http://www.verathon.com.
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte", "Deloitte & Touche", "Deloitte Touche Tohmatsu" or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.
Deloitte & Touche USA LLP is the U.S. member firm of Deloitte Touche Tohmatsu. In the U.S., services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP.
Media Contact: Jane Mueller, VP of Marketing, Verathon Medical Inc., 425.867.1348, Ext. 6060. Also: Carol Klimas, OffMadisonAve, 480.505.4527. Alternate Contacts: Joyce Chee - Marketing, 425.867.1348, Ext. 6064; Jessica McNerney, Executive Assistant to Gerald McMorrow, Verathon Inc., 425.867.1348, Ext. 1448.
Copyright 2007, Verathon Inc. BladderScan(R), GlideScope(R), GVL(R), Verathon(R), and Verathon Medical(R) are either registered trademarks or trademarks of Verathon Inc. in the United States and/or other countries. All rights reserved.
|SOURCE Verathon Inc.|
Copyright©2007 PR Newswire.
All rights reserved